Home › Pathophysiology › Ulcerative Colitis: Pathophysiology and Clinical Presentation

Ulcerative Colitis

For medical students2 min readUpdated 2026-10-10

Ulcerative colitis is a chronic inflammatory bowel disease characterized by diffuse mucosal inflammation of the large intestine with a prominent immunopathological component. The condition features severe ulcerating and destructive tissue changes, leading to significant systemic digestive disorders.

LocalizationThe inflammatory and destructive process affects exclusively the large intestine.

Peak AgeThe disease most commonly manifests in young adults aged 20 to 40 years.

GeneticsThe risk of developing the pathology is increased 15-fold in first-degree relatives of affected patients.

EpidemiologyThe condition occurs with a prevalence of over 200 clinical cases per 100,000 population.

Epidemiology and Patient Profile

The disease shows no marked gender predilection; medical statistics confirm that both men and women are affected with equal frequency. Although the disease can debut at any age and occurs across all age groups, the incidence curve displays a distinct peak. The majority of initial diagnoses are made in young, socially active individuals aged 20 to 40 years. In the general population, the disease is widespread, with epidemiological data recording over 200 cases per 100,000 population.

Polyetiological Nature of the Disease

The development of this pathology cannot be attributed to a single cause. It is a classic example of a polyetiological disease where several critical factors converge to trigger the ulcerodestructive process:

Genetic Predisposition. Heredity plays a critical role in pathogenesis. Physicians regularly note familial clustering of cases. Data show that if an individual has a first-degree relative with this diagnosis, their own risk of developing the disease is 15 times higher than in the general population. At the molecular level, this predisposition is closely linked to the carriage of specific human leukocyte antigens — HLA-DR2 and B27.
Immunological Factors. Tissue injury is driven by hyperergic immunogenic states. The body undergoes profound sensitization, particularly to dietary protein components. A cascade of immunopathological reactions is triggered, ranging from hypersensitivity reactions to the breakdown of pathological immune tolerance, which sustains chronic inflammation.
Neuropsychiatric Disorders. Gastrointestinal pathology is closely intertwined with the nervous system. Patients frequently present with comorbid psychological and emotional disturbances, including pronounced asthenia, pathological anxiety, and deep apathy.

Clinical Manifestations

Chronic immunopathological inflammation and ulcerodestructive changes in the colonic wall inevitably lead to severe dysfunction. The clinical presentation comprises a complex of characteristic symptoms:

Acute dyspeptic disorders predominate, including persistent nausea and diarrhea.
A pronounced pain syndrome develops, most frequently localized in the abdominal region.
Destruction of vascular walls within mucosal ulcerations causes hemorrhagic manifestations, which inevitably result in anemia due to chronic blood loss.
The disease is accompanied by systemic responses, including fever, complete loss of appetite (anorexia), and rapid weight loss.

Mnemonic

To remember the triad of risk factors, use the acronym "GIP": Genetics (HLA genes), Immunity (protein sensitization), Psyche (anxiety and apathy).

Frequently asked questions

What clinical symptoms are characteristic of ulcerative colitis?

Ulcerative colitis is characterized by both intestinal and systemic symptoms. The most significant include dyspeptic disorders (nausea, diarrhea, etc.), fever, abdominal pain, hemorrhagic syndrome, anemia, anorexia, and weight loss. The disease typically begins gradually (more rarely acutely) with the initial appearance of blood mixed in formed stool. Systemic manifestations include weight loss, hepatosplenomegaly, and a significantly elevated erythrocyte sedimentation rate (ESR).

What local macroscopic mucosal changes are typical for ulcerative colitis?

In ulcerative colitis, the rectum is invariably involved with a tendency for proximal spread. The inflammation is strictly limited to the mucosa. Macroscopically, the mucosa is hyperemic, and folds are flattened and edematous. Characteristic changes include:

Multiple erosions and small ulcers creating a 'moth-eaten' appearance of the tissue.
In later stages, large ulcers measuring 1–1.5 cm in depth with undermined edges develop, their bases covered by a fibrin layer (typically along the teniae coli).
Polyps (inflammatory hypertrophy of preserved mucosa, pseudopolyps) up to 1 cm in diameter form around the ulcers.
In the acute phase, contact bleeding and loss of haustrations are observed, while the remission phase features the 'lead pipe' sign (a rigid colon lacking haustra).

How does ulcerative colitis differ from Crohn's disease?

Ulcerative colitis and Crohn's disease have several significant differences in the localization and nature of the inflammatory process.

Feature	Ulcerative Colitis (UC)	Crohn's Disease
Anatomic Distribution	Colon only (rectum is always involved)	Any part of the GI tract (mouth to anus), typically the ileocecal region
Spread Pattern	Continuous involvement extending proximally	Segmental ("skip") lesions
Depth of Inflammation	Superficial (limited to mucosa and submucosa)	Transmural (all layers of the bowel wall)
Specific Histology	Crypt abscesses, pseudopolyps	Non-caseating sarcoidal granulomas, fissuring ulcers ("cobblestone" appearance)
Prognosis	Follows a course of relapses and remissions	Incurable by medical or surgical means

What life-threatening complications can develop in ulcerative colitis?

Ulcerative colitis can lead to acute and chronic life-threatening complications. An acute complication is toxic megacolon (toxic dilatation), caused by paralytic changes in the smooth muscle cells of the bowel wall and loss of tone, leading to marked colonic dilatation with a high risk of mortality. Other acute risks include bowel perforation leading to peritonitis and profuse massive gastrointestinal bleeding. A chronic life-threatening complication is malignant transformation into colorectal cancer, the risk of which correlates directly with the duration of the disease.

What pathogenetic mechanisms underlie the immunological factor in ulcerative colitis?

The immunological mechanism of UC pathogenesis represents a cascade of reactions. Bacterial antigens interact with colonocyte receptors and enter the lamina propria, where they are presented to the immune system, triggering the synthesis of pro-inflammatory cytokines. Interleukin-23 (IL-23) plays a key role by binding to receptors on naive T cells and differentiating them into Th17 cells. Th17 cells produce IL-17, which mediates chronic inflammation and initiates autoimmunity. T-cell dysfunction is thought to lead to direct cytotoxicity against colonic mucosal cells. Hyperergic states (sensitization to food proteins), allergic reactions, and the breakdown of immune tolerance are also documented.

Which part of the gastrointestinal tract is affected in this condition?

The pathological process, accompanied by ulcerodestructive changes, is localized exclusively in the large intestine (colon).

Does the incidence rate depend on the patient's sex?

No, according to epidemiological data, men and women are affected by this disease with equal frequency.

Which antigens are associated with the development of this pathology?

A close genetic association has been proven with histocompatibility antigens HLA-DR2 and B27.

Go deeper

Mechanisms of hyperergic immune reactions within the intestinal wall.
The role of food protein sensitization in sustaining chronic inflammation.
Pathogenesis of hemorrhagic syndrome and secondary anemia in intestinal ulcers.
The impact of comorbid neuropsychiatric disorders on the course of the pathology.